uniQure (QURE) FCF Margin Growth (5y) (2021 - 2026)
uniQure (QURE) FCF Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 886,714.00 |
| Dec 31, 2025 | -127,799.00 |
| Sep 30, 2025 | 161,525.00 |
| Jun 30, 2025 | 130,242.00 |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 5,261.00 |
| Sep 30, 2024 | 70,396.00 |
| Jun 30, 2024 | 72,793.00 |
| Mar 31, 2024 | 160,636.00 |
| Dec 31, 2023 | 38,450.00 |
| Sep 30, 2023 | 330,115.00 |
| Jun 30, 2023 | -183,745.00 |
| Mar 31, 2023 | -87,936.00 |
| Dec 31, 2022 | 68,736.00 |
| Sep 30, 2022 | -295,542.00 |
| Jun 30, 2022 | -367,124.00 |
| Mar 31, 2022 | -125,059.00 |
| Dec 31, 2021 | 13,046.00 |
| Sep 30, 2021 | -102,594.00 |
| Jun 30, 2021 | 165,726.00 |